Literature DB >> 11795275

Evidence for the physiological and pathological roles of adrenomedullin from genetic engineering in mice.

Y Imai1, T Shiindo, K Maemura, Y Kurihara, R Nagai, H Kurihara.   

Abstract

Adrenomedullin (AM) has been implicated as having hypotensive as well as protective effects on organs and vessels against different kinds of injuries. To elucidate the in vivo pathophysiological roles of adrenomedullin, we established transgenic mice (AMTg) overexpressing adrenomedullin driven by preproendothelin-1 promoter and adrenomedullin knockout mice (AMKO). Blood pressure in AMTg was significantly lower than that in wild-type mice, and AMTg was significantly resistant to lipopolysaccharide-induced septic shock and vascular injuries. On the other hand, heterozygotes of AMKO, AM(+/-), were fully viable and hypertensive as compared with wild littermates. Mice homozygous for adrenomedullin null mutation (AM-/-) were embryonic lethal, and no embryos could survive beyond the midterm of gestation. Collectively, our findings indicate the indispensable role of adrenomedullin in circulatory homeostasis and the organ protection as well as the fetal morphogenesis and the maintenance of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11795275     DOI: 10.1111/j.1749-6632.2001.tb03927.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  Expression of adrenomedullin 2 (ADM2)/intermedin (IMD) in human placenta: role in trophoblast invasion and migration.

Authors:  Madhu Chauhan; Uma Yallampalli; Yuan-Lin Dong; Gary D V Hankins; Chandrasekhar Yallampalli
Journal:  Biol Reprod       Date:  2009-06-17       Impact factor: 4.285

Review 2.  ETV2/ER71 Transcription Factor as a Therapeutic Vehicle for Cardiovascular Disease.

Authors:  Dong Hun Lee; Tae Min Kim; Joo Kyung Kim; Changwon Park
Journal:  Theranostics       Date:  2019-08-09       Impact factor: 11.556

Review 3.  Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.

Authors:  Ramiro Vázquez; Maria E Riveiro; Caroline Berenguer-Daizé; Anthony O'Kane; Julie Gormley; Olivier Touzelet; Keyvan Rezai; Mohamed Bekradda; L'Houcine Ouafik
Journal:  Front Oncol       Date:  2021-01-06       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.